What is it about?
This article reviews the challenges in conducting trials in alpha-1 antitrypsin deficiency in order to meet the regulatory requirements of governmental agencies.
Featured Image
Why is it important?
The article not only reviews the difficulties, but suggests potential solutions.
Read the Original
This page is a summary of: Trials and Tribulations: An Industry Perspective on Conducting Registrational Trials in Alpha-1 Antitrypsin Deficiency, Annals of the American Thoracic Society, August 2016, American Thoracic Society,
DOI: 10.1513/annalsats.201510-672kv.
You can read the full text:
Contributors
The following have contributed to this page
